Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Celgene to apply machine learning to market access

Signs agreement for rights to GNS Healthcare's simulation platform

Digital pharma Celgene GNS HealthcareCelgene is set to apply machine learning to market access, commercialisation and drug discovery through a partnership with GNS Healthcare.

GNS applies causal machine learning technology to massive and diverse data streams to better match drugs and other health interventions to individual patients.

The service and license arrangement with Celgene covers its REFS (Reverse Engineering and Forward Simulation) causal machine learning and simulation platform.

The deal, which involves Celgene's second equity investment in the firm, will also see several GNS causal modeling experts brought in-house at the biopharma company's sites to operate the platform.

Iya Khalil, chief commercial officer and co-founder of GNS, said: “Companies that embrace data-driven frameworks and culture such as Celgene are gaining a competitive advantage to rapidly generate insights that are simply not possible with any other analytics methodology.”

In addition to Celgene, GNS has previously worked with the likes of J&J, Novartis, Covance and the US National Institutes of Health.

5th January 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics